WOAG
WITHDRAWAL OF ATTORNEY GRANTED
19/08/2021
Voltar para busca
Dado oficial do USPTO
FIVEPRIME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
19/08/2021
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
09/01/2003
Data de registro
12/02/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/08/2018
Última transação
01/08/2018
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/04/2007
Primeiro uso no comércio
17/04/2007
Código do desenho
3
Tipo de titular
03
Localização do titular
South San Francisco, CA, US
Examinador
SINGH, TEJBIR
Unidade examinadora
L60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Representantes
Five Prime Therapeutics, Inc.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the diagnosis of human diseases or human health-related conditions, with diagnosis being limited to the identification of human patient populations for administering preventatives or therapeutics and monitoring the human patient populations' response thereto; pharmaceutical preparations for the prevention or treatment of human diseases or human health-related conditions
Classe 42
Research of pharmaceutical products for the diagnosis of human disease or human health-related conditions, with diagnosis being limited to the identification of human patient populations for administering preventatives or therapeutics and monitoring the human patient populations' response thereto; research of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; development and design of pharmaceutical products for the diagnosis, prevention, or treatment of human diseases or human health-related conditions; testing of pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; pharmaceutical product and technology consultation and screening services
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
19/08/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/08/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/08/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/08/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
19/07/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/07/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/01/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/01/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/02/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/08/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/08/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2014
E815
TEAS SECTION 8 & 15 RECEIVED
29/07/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/04/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/04/2012
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/05/2008
PLGL
ASSIGNED TO PARALEGAL
07/04/2008
ES7R
TEAS SECTION 7 REQUEST RECEIVED
21/02/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/01/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/01/2008
ALIE
ASSIGNED TO LIE
04/01/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/12/2007
IUAF
USE AMENDMENT FILED
19/11/2007
PAPER RECEIVED
19/11/2007
CORV
REVIEW OF CORRESPONDENCE COMPLETE
15/08/2007
FAXX
FAX RECEIVED
13/08/2007
EX5G
SOU EXTENSION 5 GRANTED
13/08/2007
EXT5
SOU EXTENSION 5 FILED
11/05/2007
EEXT
SOU TEAS EXTENSION RECEIVED
11/05/2007
EX4G
SOU EXTENSION 4 GRANTED
12/01/2007
EXT4
SOU EXTENSION 4 FILED
08/11/2006
PAPER RECEIVED
08/11/2006
EX3G
SOU EXTENSION 3 GRANTED
13/06/2006
EXT3
SOU EXTENSION 3 FILED
23/05/2006
PAPER RECEIVED
23/05/2006
EX2G
SOU EXTENSION 2 GRANTED
18/11/2005
EXT2
SOU EXTENSION 2 FILED
02/11/2005
PAPER RECEIVED
02/11/2005
DOCK
ASSIGNED TO EXAMINER
11/08/2005
EX1G
SOU EXTENSION 1 GRANTED
08/06/2005
EXT1
SOU EXTENSION 1 FILED
20/05/2005
PAPER RECEIVED
20/05/2005
DOCK
ASSIGNED TO EXAMINER
07/01/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
23/11/2004
PUBO
PUBLISHED FOR OPPOSITION
31/08/2004
NPUB
NOTICE OF PUBLICATION
11/08/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2004
CNEA
EXAMINERS AMENDMENT MAILED
27/05/2004
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
25/05/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2004
PAPER RECEIVED
29/03/2004
CNFR
FINAL REFUSAL MAILED
05/02/2004
CFIT
CASE FILE IN TICRS
08/12/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2003
PAPER RECEIVED
06/11/2003
CNRT
NON-FINAL ACTION MAILED
25/06/2003
DOCK
ASSIGNED TO EXAMINER
23/06/2003
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FIVEPRIME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.